Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model. (Q53629730)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model. |
scientific article |
Statements
Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model. (English)
Syed M Abbas Rizvi
Yong Li
Emma Yan Jun Song
Chang Fa Qu
Chand Raja
Alfred Morgenstern
Christos Apostolidis
Barry J Allen
4 April 2006
5
4
386-393